Viral ocular manifestations: A broad overview

Reviews in Medical Virology

Volumn 23, Issue 5, 2013, Pages 281-294

  Newman, Howard ^a   Gooding, Caroline ^a  

^a STELLENBOSCH UNIVERSITY   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; ANTIRETROVIRUS AGENT; CORTICOSTEROID; DOUBLE STRANDED DNA; FAMCICLOVIR; FOMIVIRSEN; FOSCARNET; GANCICLOVIR; TRIFLURIDINE; VALACICLOVIR;

ADENOVIRUS; AFRICA; BK VIRUS; CATARACT; CHIKUNGUNYA; CORTICOSTEROID THERAPY; CYTOMEGALOVIRUS; DISEASE ASSOCIATION; ENTEROVIRUS; EPISCLERITIS; HEMORRHAGIC FEVER; HEPATITIS C VIRUS; HERPES SIMPLEX VIRUS 1; HERPES VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN T CELL LEUKEMIA VIRUS 1; INFLUENZA; MEASLES VIRUS; MOLLUSCUM CONTAGIOSUM; MORBIDITY; MUMPS; NONHUMAN; PREVALENCE; RETINITIS; REVIEW; RUBELLA VIRUS; UVEITIS; VARICELLA ZOSTER VIRUS; VIRAL CONJUNCTIVITIS; VIRUS KERATITIS; WART VIRUS;

EID: 84882715443     PISSN: 10529276     EISSN: 10991654     Source Type: Journal    
DOI: 10.1002/rmv.1749     Document Type: Review

References (84)

1. Male D, Brostoff J, Roth DB, Roitt I. Immunology. Elsevier limited: Canada, 2006.
2. Lima B. Ophthalmic manifestations of HIV infection. Digital Journal of Ophthalmology 2004; 10(3). Available from : http://www.djo.harvard.edu/print.php?url=/physicians/oa/674&print=1
3. Belfort R. The ophthalmologist and the global impact of the AIDS epidemic LV Edward Jackson Memorial Lecture. American Journal of Ophthalmology 2000; 129(1): 1-8.
4. Cunningham E, Margolis T. Ocular manifestations of HIV infection. The New England Journal of Medicine 1998; 339(4): 236-244.
5. Govendera P, Hansrajb R, Naidooc K, Visser L. Ocular manifestations of HIV/AIDS: a literature review (part 1). The South African Optometrist 2010; 69(4): 193-199.
6. Kaleem M, Ramsahai S, Del Fierro K, Rasul S, Onumah C. Ocular findings in human immunodeficiency virus patients in Washington, DC. International Ophthalmology 2012; 32(2): 145-51.
7. Pillay D, Geretti A, Weiss R. Human immunodeficiency viruses. In Principles and Practice of Clinical Virology, Zuckerman A, Banatvala J, Schoub B, Griffiths P, Mortimer P (eds). John Wiley & Sons Ltd: Chichester, 2009; 897-938.
8. Moraes H. Ocular manifestations of HIV/AIDS. Current Opinion in Ophthalmology 2002; 13(6): 397-403.
9. Up-to-date. Epidemiology of herpes simplex virus type-1 infection. http://www.uptodate.com/ [1 October 2010].
10. Up-to-date. Epidemiology, clinical manifestations, and diagnosis of genital herpes simplex virus infection. http://www.uptodate.com/ [30 March 2012].
11. Masuet-Aumatell C, Ramon-Torrell JM, Casanova A, Navarro MB, Gamboa MdRD, Rodríguez SLM. Seroprevalence of varicella-zoster virus infection in children from Cochabamba: tropical or temperate pattern? Tropical Medicine & International Health 2012. DOI: 10.1111/tmi.12040
12. Up-to-date. Epidemiology, clinical manifestations, and treatment of cytomegalovirus infection in immunocompetent hosts.http://www.uptodate.com/ [5 April 2012].
13. Up-to-date. Infectious mononucleosis in adults and adolescents. http://www.uptodate.com/ [31 May 2012].
14. Ansari A, Li S, Abzug M, Weinberg A. Human herpesviruses 6 and 7 and central nervous system infection in children. Emerging Infectious Diseases 2004; 10(8): 1450-1454.
15. Adjei A, Armah H, Gbagbo F, Boamah I, Adu-Gyamfi C, Asare I. Seroprevalence of HHV-8, CMV, and EBV among the general population in Ghana, West Africa. BMC Infectious Diseases 2008; 8(1): 111.
16. Simmons A. Clinical manifestations and treatment considerations of herpes simplex virus infection. Journal of Infectious Diseases 2002; 186(1): S71-S77.
17. Farooq A, Shah A, Shukla D. The role of herpesviruses in ocular infections. Virus Adaptation and Treatment 2010; 2: 115-123.
18. Dawson C, Togni B. Herpes simplex eye infections: clinical manifestations, pathogenesis and management. Survey of Ophthalmology 1976; 21(2): 121-135.
19. Aurelian L. Herpes simplex viruses: general features. In Encyclopedia of Virology, Mahy B, van Regenmortel M (eds). Elsevier Academic Press: Philadelphia, 2008; 383-397.
20. Ritterband D, Friedberg D. Virus infections of the eye. Reviews in Medical Virology 1998; 8: 187-201.
21. Krachmer J, Mannis M, Holland E. Fundamentals, diagnosis and management, volume 1. In Cornea. Elsevier Inc: Edinburgh, 2005; 629-636, 1065-1071, 1086-1089, 1095-1098.
22. Forsgren M, Klapper P. Herpes simplex virus type 1 and type 2. In Principles and Practice of Clinical Virology, Zuckerman A, Banatvala J, Schoub B, Griffiths P, Mortimer P (eds). John Wiley & Sons Ltd: Chichester, 2009; 95-131.
23. Preiser W, Doerr H, Buxbaum S, Rabenau H, Baatz H. Acute retinal necrosis six years after herpes simplex encephalitis: an elusive immune deficit suggested by insufficient test sensitivity. Journal of Medical Virology 2004; 73: 250-255.
24. De Groot-Mijnes JD, Rothova A, Van Loon AM, et al. Polymerase chain reaction and Goldmann-Witmer coefficient analysis are complimentary for the diagnosis of infectious uveitis. American Journal of Ophthalmology 2006; 141(2): 313-318.
25. Kanski J, Bowling B. Clinical Ophthalmology: A Systematic Approach. Elsevier limited: Edinburgh, 2011.
26. Griffiths P. Cytomegalovirus. In Principles and Practice of Clinical Virology, Zuckerman A, Banatvala J, Schoub B, Griffiths P, Mortimer P (eds). John Wiley & Sons Ltd: Chichester, 2009; 161-197.
27. Jabs D, Martin B, Forman M, Ricks M. Cytomegalovirus (CMV) blood DNA load, CMV retinitis progression, and occurrence of resistant CMV in patients with CMV retinitis. Journal of Infectious Diseases 2005; 192(4): 640-649.
28. Baldassano V, Dunn J, Feinberg J, Jabs D. Cytomegalovirus retinitis and low CD4+ T-lymphocyte counts. The New England Journal of Medicine 1995; 333(670). DOI: 10.1056/NEJM199509073331019.
29. Chee S, Bacsal K, Jap A, Se-Thoe S, Cheng C, Tan B. Clinical features of cytomegalovirus anterior uveitis in immunocompetent patients. American Journal of Ophthalmology 2008; 145(5): 834-840.
30. Silverstein B, Conrad D, Margolis T, Wong I. Cytomegalovirus-associated acute retinal necrosis syndrome. American Journal of Ophthalmology 1997; 123(2): 257-258.
31. O'Connell N, Freeman N, Rabie H, Cotton M. Presumed cytomegalovirus retinitis in human immunodeficiency virus type I-infected South African children. The Pediatric Infectious Disease Journal 2011; 30(6): 539-540.
32. Rafailidis P, Mourtzoukou E, Varbobitis I, Falagas M. Severe cytomegalovirus infection in apparently immunocompetent patients: a systematic review. Virology Journal 2008; 5(47). DOI: 10.1186/1743-422X-5-47.
33. Jabs D, Enger C, Dunn J, Forman M, Hubbard L. Cytomegalovirus retinitis and viral resistance: 3. Culture results. American Journal of Ophthalmology 1998; 26(4): 543-549.
34. Myhre H, Haug Dorenberg D, Kristiansen K, et al. Incidence and outcomes of ganciclovir-resistant cytomegalovirus infections in 1244 kidney transplant recipients. Transplantation 2011; 92(2): 217-223.
35. Pepose J. The potential impact of the varicella vaccine and new antivirals on ocular disease related to varicella-zoster virus. American Journal of Ophthalmology 1997; 123(2): 243-251.
36. Breuer J. Varicella zoster. In Principles and Practice of Clinical Virology, Zuckerman A, Banatvala J, Schoub B, Griffiths P, Mortimer P (eds). John Wiley & Sons Ltd: Chichester, 2009; 133-160.
37. Svozílková P, Říhová E, Diblík P, Kuthan P, Kovařík Z, Kalvodová B. Varicella zoster virus acute retinal necrosis following eye contusion: case report. Virology Journal 2005; 2(77). DOI: 10.1186/1743-422X-2-77.
38. Burke D, Kalayjian R, Vann V, Madreperla S, Shick E, Leonard D. Polymerase chain reaction detection and clinical significance of varicella-zoster virus in cerebrospinal fluid from human immunodeficiency virus-infected patients. Journal of Infectious Diseases 1997; 176(4): 1080-1084.
39. Haque T, Crawford D. Epstein-Barr virus. In Principles and Practice of Clinical Virology, Zuckerman A, Banatvala J, Schoub B, Griffiths P, Mortimer P (eds). John Wiley & Sons Ltd: Chichester, 2009; 199-221.
40. Slobod K, Sandlund J, Spiegel P, et al. Molecular evidence of ocular Epstein-Barr virus infection. Clinical Infectious Diseases 2000; 31(1): 184-188.
41. Willoughby C, Baker K, Kaye S, et al. Epstein-Barr virus (types 1 and 2) in the tear film in Sjogren's syndrome and HIV infection. Journal of Medical Virology 2002; 68(3): 378-383.
42. Lemaitre C, Bodaghi B, Murat F, et al. EBV-associated uveitis diagnosed by polymerase chain reaction (PCR): report of 3 cases. Investigative Ophthalmology & Visual Science 2004; 45(E-Abstract 1670): 1670-B481.
43. Ongkosuwito J, Van der Lelij A, Bruinenberg M, et al. Increased presence of Epstein-Barr virus DNA in ocular fluid samples from HIV negative immunocompromised patients with uveitis. British Journal of Ophthalmology 1998; 82(3): 245-251.
44. Méchaï F, Boutolleau D, Manceron V, et al. Human herpesvirus 6-associated retrobulbar optic neuritis in an HIV-infected patient: response to anti-herpesvirus therapy and long-term outcome. Journal of Medical Virology 2007; 79(7): 931-934.
45. Chan C. Molecular pathology of primary intraocular lymphoma. Transactions of the American Ophthalmological Society 2003; 101: 275-292.
46. Benko M. Adenoviruses: pathogenesis. In Encyclopaedia of Virology, Mahy B, van Regenmorte lM (eds). Elsevier: Philadelphia, 2008; 24-29.
47. Leppard K. Adenoviruses: molecular biology. In Encyclopedia of Virology, Mahy B, van Regenmorte lM (eds). Elsevier: Philadelphia, 2008; 17-23.
48. Abelson M, Shapiro A. The many faces of adenovirus. Review of Ophthalmology 2010; 17(3): 66-69.
49. Bialasiewicz A. Adenoviral keratoconjunctivitis. Sultan Qaboos University Medical Journal 2007; 17(1): 15-23.
50. Maitreyi R, Dar L, Muthukumar A, et al. Acute hemorrhagic conjunctivitis due to enterovirus 70 in India. Emerging Infectious Diseases 1999; 5(2): 267-269.
51. Lashkevich V, Koroleva G, Lukashev A, Ekaterina V, Denisova E, Katargina L. Enterovirus uveitis. Reviews in Medical Virology 2004; 14(4): 241-254.
52. Kaye S, Morton C, Tong W, O'Donell N. Echovirus keratoconjunctivitis. American Journal of Ophthalmology 1998; 125(2): 187-190.
53. Minor P, Muir P. Enteroviruses. In Principles and Practice of Clinical Virology, Zuckerman A, Banatvala J, Schoub B, Griffiths P, Mortimer P (eds). John Wiley & Sons Ltd: Chichester, 2009; 601-624.
54. Langford M, Ball W, Ganley J. Inhibition of the enteroviruses that cause acute hemorrhagic conjunctivitis (AHC) by benzimidazoles; enviroxime (LY 122772) and enviradone (LY 127123). Antiviral Research 1995; 27(4): 355-365.
55. Harvala H, Simmonds P. Human parechoviruses: biology, epidemiology and clinical significance. Journal of Clinical Virology 2009; 45(1): 1-9.
56. de Groot-Mijnes JD, de Visser L, Zuurveen S, et al. Identification of new pathogens in the intraocular fluid of patients with uveitis. American Journal of Ophthalmology 2010; 150(5): 628-36.
57. Vijayalakshmi P, Kakkar G, Samprathi A Banushree R. Ocular manifestations of congenital rubella syndrome in a developing country. Indian Journal of Ophthalmology 2002; 50: 307-11.
58. Gregg N, Banatvala J. Congenital cataract following German measles in the mother.Reviews in Medical Virology 2001; 11: 277-285.
59. Best J, Icenogle J, Brown D. Rubella. In Principles and Practice of Clinical Virology, Zuckerman A, Banatvala J, Schoub B, Griffiths P, Mortimer P (eds). John Wiley & Sons Ltd: Chichester, 2009; 561-592.
60. De Visser L, Braakenburg A, Rothova A, De Boer J. Rubella virus-associated uveitis: clinical manifestations and visual prognosis. American Journal of Ophthalmology 2008; 146(2): 292-297.
61. Suzuki J, Goto H, Komase K, et al. Rubella virus as a possible etiological agent of Fuchs heterochromic iridocyclitis. Graefe's Archive for Clinical and Experimental Ophthalmology 2010; 248(10): 1487-1491.
62. Wensing B, Relvas LM, Caspers LE, et al. Comparison of rubella virus- and herpes virus-associated anterior uveitis: clinical manifestations and visual prognosis. Ophthalmology 2011; 118(10): 1905-1910.
63. Givens K, Lee D, Jones T, Ilstrup D. Congenital rubella syndrome: ophthalmic manifestations and associated systemic disorders. British Journal of Ophthalmology 1993; 77(6): 358-363.
64. Perry R, Halsey N. The clinical significance of measles: a review. Journal of Infectious Diseases 2004; 189(1): S4-S16.
65. Asaria P, MacMahon E. Measles in the United Kingdom: can we eradicate it by 2010? BMJ 2006; 333(7574): 890-895.
66. Kuiken T, Riteau B, Fouchier R, Rimmelzwaan G. Pathogenesis of influenza virus infections: the good, the bad and the ugly. Current Opinion in Virology 2012; 2(3): 276-286.
67. Fouchier R, Schneeberger P, Rozendaal F, et al. Avian influenza A virus (H7N7) associated with human conjunctivitis and a fatal case of acute respiratory distress syndrome. PNAS 2004; 101(5): 1356-1361.
68. Goncalves D, Proietti F, Ribas J, et al. Epidemiology, treatment, and prevention of human T-cell leukemia virus type 1-associated diseases. Clinical Microbiology Reviews 2010; 23(3): 577-589.
69. Buggage R. Ocular manifestations of human T-cell lymphotropic virus type 1 infection. Current Opinion in Ophthalmology 2003; 14(6): 420-425.
70. Reploeg M, Storch G, Clifford D. BK virus: a clinical review. Clinical Infectious Diseases 2001; 33(2): 191-202.
71. Hedquist B, Bratt G, Hammarin A, et al. Identification of BK virus in a patient with acquired immune deficiency syndrome and bilateral atypical retinitis. Ophthalmology 1999; 106(1): 129-32.
72. Gupta R, Best J, MacMahon E. Mumps and the UK epidemic2005. BMJ 2005; 330(7500): 1132-1135.
73. North D. Ocular complications of mumps. British Journal of Ophthalmology 1953; 37(2): 99-101.
74. Onal S, Toker E. A rare ocular complication of mumps: kerato-uveitis. Ocular Immunology and Inflammation 2005; 13(5): 395-397.
75. Jarhling P. Viral haemorrhagic fevers. In Textbook of Military Medicine, Zajtchuk R (ed). Office of The Surgeon General Department of the Army: United States of America, 1997; 591-602.
76. Al-Hazmi A, Al-Rajhi A, Abboud E, et al. Ocular complications of Rift Valley fever outbreak in Saudi Arabia. Ophthalmology 2005; 112(2): 313-318.
77. Lim W, Mathur R, Koh A, Yeoh R, Chee S. Ocular manifestations of dengue fever. Ophthalmology 2004; 111(11): 2057-2064.
78. Mahendradas P, Ranganna S, Shetty R, et al. Ocular manifestations associated with Chikungunya. Ophthalmology 2008; 115(2): 287-291.
79. Jacobi C, Wenkel H, JacobiI A, Korn K, Cursiefen C, Kruse F. Hepatitis C and ocular surface disease. American Journal of Ophthalmology 2007; 144(5): 705-711.
80. Schornack M, Siemsen D, Bradley E, Salomao D, Lee H. Ocular manifestations of molluscum contagiosum. Clinical & Experimental Optometry 2006; 89(6): 390-393.
81. Charteris D, Bonshek R, Tullo A. Ophthalmic molluscum contagiosum: clinical and immunopathological features. British Journal of Ophthalmology 1995; 79(5): 476-481.
82. Karcioglu ZA, Issa TM. Human papilloma virus in neoplastic and non-neoplastic conditions of the external eye. British Journal of Ophthalmology 1997; 81(7): 595-598.
83. Gray RH, Johnson GJ, Freedman A. Climatic droplet keratopathy. Survey of Ophthalmology 1992; 36(4): 241-253.
84. Miller DM, Brodell RT, Levine MR. The conjunctival wart: report of a case and review of treatment options. Ophthalmic Surgery 1994; 25(8): 545-548.